# Inovio

Type: Company (INO)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/inovio
Canonical HTML page: https://getfinancebrief.com/entity/inovio

## Recent coverage (1 stories)

### Tech and Biotech Pivot: LivePerson, Inovio, and Bakkt Realign for 2026 Growth
2026-03-18 00:33:36 · Sentiment: Neutral · Impact: 6/10 · Sources: 3

LivePerson, Inovio, and Bakkt reported Q4 2025 results highlighting strategic transitions toward AI integration, regulatory milestones, and balance sheet restructuring. While LivePerson capitalizes on generative AI adoption and Inovio nears a critical FDA PDUFA date, Bakkt has streamlined its capital structure to focus on institutional crypto services.
Full story: https://getfinancebrief.com/story/lpsn-ino-bkkt-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.